CA63624/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1996	3
1997	4
1998	2
1999	3
2000	1
2024	0

1

Cytotoxicity with Auger electron-emitting radionuclides delivered by antibodies.

Griffiths GL, Govindan SV, Sgouros G, Ong GL, Goldenberg DM, Mattes MJ. Griffiths GL, et al. Int J Cancer. 1999 Jun 11;81(6):985-92. doi: 10.1002/(sici)1097-0215(19990611)81:6<985::aid-ijc23>3.0.co;2-w. Int J Cancer. 1999. PMID: 10362149

2

Processing of antibodies bound to B-cell lymphomas and lymphoblastoid cell lines.

Vangeepuram N, Ong GL, Mattes MJ. Vangeepuram N, et al. Cancer. 1997 Dec 15;80(12 Suppl):2425-30. doi: 10.1002/(sici)1097-0142(19971215)80:12+<2425::aid-cncr14>3.3.co;2-d. Cancer. 1997. PMID: 9406693

3

Advantage of a residualizing iodine radiolabel for radioimmunotherapy of xenografts of human non-small-cell carcinoma of the lung.

Stein R, Goldenberg DM, Thorpe SR, Mattes MJ. Stein R, et al. J Nucl Med. 1997 Mar;38(3):391-5. J Nucl Med. 1997. PMID: 9074526 Free article.

4

Internalization and catabolism of radiolabelled antibodies to the MHC class-II invariant chain by B-cell lymphomas.

Hansen HJ, Ong GL, Diril H, Valdez A, Roche PA, Griffiths GL, Goldenberg DM, Mattes MJ. Hansen HJ, et al. Biochem J. 1996 Nov 15;320 ( Pt 1)(Pt 1):293-300. doi: 10.1042/bj3200293. Biochem J. 1996. PMID: 8947500 Free PMC article.

5

Enhancement of tumor-to-nontumor localization ratios by hepatocyte-directed blood clearance of antibodies labeled with certain residualizing radiolabels.

Patel S, Stein R, Ong GL, Goldenberg DM, Mattes MJ. Patel S, et al. J Nucl Med. 1999 Aug;40(8):1392-401. J Nucl Med. 1999. PMID: 10450693 Free article.

6

Manipulation of blood clearance to optimize delivery of residualizing label-antibody conjugates to tumor cells in vivo.

Stein R, Goldenberg DM, Ong GL, Thorpe SR, Mattes MJ. Stein R, et al. J Nucl Med. 1997 Sep;38(9):1392-400. J Nucl Med. 1997. PMID: 9293796 Free article.

7

Rapid blood clearance of mouse IgG2a and human IgG1 in many nude and nu/+ mouse strains is due to low IgG2a serum concentrations.

Reddy N, Ong GL, Behr TM, Sharkey RM, Goldenberg DM, Mattes MJ. Reddy N, et al. Cancer Immunol Immunother. 1998 Mar;46(1):25-33. doi: 10.1007/s002620050456. Cancer Immunol Immunother. 1998. PMID: 9520289 Free PMC article.

8

Intracellular processing of 99Tcm-antibody conjugates.

Karacay H, Ong GL, Hansen HJ, Griffiths GL, Goldenberg DM, Mattes MJ. Karacay H, et al. Nucl Med Commun. 1998 Oct;19(10):971-9. doi: 10.1097/00006231-199810000-00007. Nucl Med Commun. 1998. PMID: 10234677

9

The advantage of residualizing radiolabels for targeting B-cell lymphomas with a radiolabeled anti-CD22 monoclonal antibody.

Mattes MJ, Shih LB, Govindan SV, Sharkey RM, Ong GL, Xuan H, Goldenberg DM. Mattes MJ, et al. Int J Cancer. 1997 May 2;71(3):429-35. doi: 10.1002/(sici)1097-0215(19970502)71:3<429::aid-ijc21>3.0.co;2-9. Int J Cancer. 1997. PMID: 9139880

10

Limitations in the use of low pH extraction to distinguish internalized from cell surface-bound radiolabeled antibody.

Ong GL, Mattes MJ. Ong GL, et al. Nucl Med Biol. 2000 Aug;27(6):571-5. doi: 10.1016/s0969-8051(00)00145-1. Nucl Med Biol. 2000. PMID: 11056371

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year